COLL vs KEYS
Collegium Pharmaceutical Inc (COLL) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the COLL and KEYS stock pages for the full models.
Not investment advice.